In idiopathic pulmonary fibrosis, GPX4 levels in pulmonary fibroblasts are reduced, and GPX4 knockdown significantly enhances TGF-β-induced SMAD2/3 activation, thereby promoting myofibroblast differentiation in lung fibroblasts [62]. The gene discussed is SMAD2; the disease is pulmonary fibrosis.